drugset / Trial / NCT05550636
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood
NaSequentialOpen-labelTreatment
Summary
The main objective of this trial is to investigate the induction effect of multiple doses of BI 1015550 on the pharmacokinetics of the sensitive CYP3A4 substrate midazolam.
Timeline
- Start
- 2022-10-11
- Primary completion
- 2022-12-19
- Completion
- 2022-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | — | — |
| Subject | Nerandomilast | Small molecule | — | — |
Indications
No indication recorded.